Why the study?
What is the comparative effectiveness of different antihypertensive drug classes in hypertensive patients?
What is the comparative effectiveness of different antihypertensive drug classes in hypertensive patients?
This review highlights that while low-dose diuretics, ACE inhibitors, and calcium antagonists are equally effective overall for hypertension, therapy should be individualized, particularly favoring ACE inhibitors in diabetic patients.
Answers are grounded in this paper and cite their sources.
Supports individualized antihypertensive selection by comorbidity; leaves open need for contemporary head-to-head RCTs.
A large number of randomized controlled trials have been published over the past decade. The earlier ones established the benefits of low-dose diuretic-based therapy. The more recent ones have documented the equal overall effectiveness of therapy based on an angiotensin-converting enzyme inhibitor or a calcium antagonist. The comparative data do not clearly define a single superior drug for most hypertensive patients, so the initial choice should be individualized, on the basis of the concomitant conditions. For the rapidly increasing population of diabetic hypertensive patients, similar conclusions are obvious, with the caveat that an angiotensin-converting enzyme inhibitor should usually be the initial choice, with diuretics and calcium antagonists usually needed to accomplish adequate control. There are no concerns about the use of calcium antagonists in diabetic patients.
No takes yet. Share an insight, caveat, or question.
Norman M. Kaplan (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: